Large-scale testing (Phase 3)Study completedNCT03227263
What this trial is testing
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).
Who this might be right for
Rendu Osler DiseaseTelangiectasia, Hereditary Hemorrhagic
Hospices Civils de Lyon 24